2013
DOI: 10.1016/j.ijom.2013.02.008
|View full text |Cite
|
Sign up to set email alerts
|

The effects of chronic zoledronate usage on the jaw and long bones evaluated using RANKL and osteoprotegerin levels in an animal model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
14
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(17 citation statements)
references
References 27 publications
2
14
0
1
Order By: Relevance
“…It is generally recognized that BRONJ pathogenesis is multifactorial. [27] Mostly accepted theories are as follows: high bone turnover of the jaws, the inhibition of angiogenesis, osteoclastic apoptosis and easy bacterial contamination of jaw bone are among the most accepted theories. [9,12,20] Osteoclastic activity in the jaw bone-containing BPs is suppressed and tissue healing would be altered.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…It is generally recognized that BRONJ pathogenesis is multifactorial. [27] Mostly accepted theories are as follows: high bone turnover of the jaws, the inhibition of angiogenesis, osteoclastic apoptosis and easy bacterial contamination of jaw bone are among the most accepted theories. [9,12,20] Osteoclastic activity in the jaw bone-containing BPs is suppressed and tissue healing would be altered.…”
Section: Resultsmentioning
confidence: 99%
“…Clinical inspection was made blindly by one of the authors. [27] Histological and histomorphometrical analysis…”
Section: Clinical Findings Assessmentmentioning
confidence: 99%
“…Because of its convenience of administration (the intravenous route is typically selected to prevent gastrointestinal irritation), its long administration interval (often 4–5 mg, once a year for OP and once a month for oncology patients) and, most importantly, its strong anti‐bone resorption effect, ZA has become a new treatment choice. Moreover, ZA is more commonly used in creating BRONJ animal models (Çankaya et al, ; Stephen, Brynmor, Gregory, Mark, & Kenneth, ; Zandi, Dehghan, Malekzadeh, et al, ) than denosumab, because the latter is a human antibody and thus could not be used directly in animal experimentation.…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies on MRONJ have used rat models. 9,[11][12][13] In accord with previous animal studies, all rats were injected intraperitoneally with zoledronic acid (0.4 mg/kg once a week) for 7 weeks. In addition, all rats were injected with dexamethasone (1 mg/kg intraperitoneally weekly at weeks 5, 6, and 7).…”
Section: Methodsmentioning
confidence: 99%